Hepatitis C elimination in people living with HIV - the importance of biomedical and behavioural interventions.
van Santen DK, Sacks-Davis R, Hellard M.
Hepatitis C elimination in people living with HIV - the importance of biomedical and behavioural interventions.
van Santen DK, Sacks-Davis R, Hellard M
Hepatitis C HIV + AIDS
The impact of universal access to direct-acting antiviral therapy on the hepatitis C cascade of care among individuals attending primary and community health services.
Traeger MW, Pedrana AE, van Santen DK, Doyle JS, Howell J, Thompson AJ, El-Hayek C, Asselin J, Polkinghorne V, Membrey D, Bramwell F, Carter A, Guy R, Stoové MA, Hellard ME, EC Victoria Partnership and the Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Blood-borne Viruses and Sexually Transmitted Infections (ACCESS)
Measuring hepatitis C virus elimination as a public health threat: Beyond global targets.
van Santen DK, Sacks-Davis R, Doyle JS, Scott N, Prins M, Hellard M
Commentary on Barré et al. (2020): Identifying remaining barriers to hepatitis C treatment in the DAA era.
Sacks-Davis R, van Santen DK, Doyle JS
High proportions of liver fibrosis and cirrhosis in an ageing population of people who use drugs in Amsterdam, The Netherlands.
van Santen DK, Schim van der Loeff MF, Cartier van Dissel J, Martens JPD, van der Valk M, Prins M